Balanced news tone
News Sentiment
XERS sentiment intelligence
Xeris Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
32 relevant articles
News tone and price action are not far from neutral.
91/100 classification confidence.
directly relevant articles
high-authority source matches
+0.7% over one week, +22.8% over four weeks, trend inactive, and materially above fair value.
Enterprise value to revenue forward of Xeris Biopharma Holdings, Inc. – NASDAQ:XERS
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
91/100 classification
One-week reaction
0.7%
Price digesting
Trend fit
Trend inactive
22.8% over four weeks
Fair value
94.0%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
3
Neutral
29
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
Zacks Investment Research
Direct company coverage
Xeris Pharmaceuticals (XERS)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Jun 2018 10:13
- Source
- Zacks Investment Research
TradingView
Direct company coverage
XERS Stock Price and Chart — NASDAQ:XERS
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jun 2018 02:45
- Source
- TradingView